Clinical Trials

NCT07275723 | COMPLETED | PHASE3
309 participants

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-30
Start Date:
2025-11-14
Completion:
2026-04-18
Conditions
  • For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)
Interventions
  • DRUG
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page